Company Profile
Artelo Biosciences Stock Price, News & Analysis
- Ticker:
- ARTL
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Artelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
1.26 USD (+2.44%)
Close
Last updated: June 23, 2026 at 00:00
4.39M USD
Market cap
Why the stock is moving
ARTL is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Artelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Artelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Artelo Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Artelo Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Artelo Biosciences Announces Reverse Stock Split
Source: Artelo Biosciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Artelo Biosciences (ARTL)?
Artelo Biosciences (ARTL) most recently closed at 1.26 USD, a +2.44% move versus the previous session.
What is the market cap of Artelo Biosciences (ARTL)?
Artelo Biosciences currently has a market capitalization of 4.39M USD on BioPharmSignal.
What does Artelo Biosciences do?
Artelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is ARTL stock listed?
Artelo Biosciences (ARTL) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Artelo Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Artelo?
Artelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Artelo Biosciences targeting with Artelo?
Artelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Artelo Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.